The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges - PubMed (original) (raw)
Review
The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges
David R Greaves et al. J Lipid Res. 2009 Apr.
Abstract
It is now thirty years since the original observation that macrophages take up and degrade modified forms of low density lipoprotein (LDL). Molecular cloning has identified multiple scavenger receptors that can endocytose modified LDL and binding studies continue to identify a wide range of scavenger receptor ligands displayed by bacterial pathogens, modified self proteins and apoptotic cells. Scavenger receptors drive macrophage foam cell development in vitro but their exact role in the development of atherosclerosis remains difficult to assess critically. This could be due in part to functional redundancy or it could perhaps reflect our incomplete appreciation of all the potential roles of this family of receptors in host defense and tissue homeostasis. In this brief overview of the extensive literature in this area we emphasize the continuing duality of scavenger receptors as sensors of both nonself (pathogens) and modified self (modified forms of LDL and apoptotic cells). We highlight some under-appreciated roles of scavenger receptors in macrophage biology (e.g., regulation of macrophage cytokine responses) and we speculate on potential approaches to target the activity of this diverse family of receptors for therapeutic benefit in cardiovascular disease.
Similar articles
- Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors.
Greaves DR, Gordon S. Greaves DR, et al. J Lipid Res. 2005 Jan;46(1):11-20. doi: 10.1194/jlr.R400011-JLR200. Epub 2004 Nov 16. J Lipid Res. 2005. PMID: 15548472 Review. - Scavenger receptors in atherosclerosis: beyond lipid uptake.
Moore KJ, Freeman MW. Moore KJ, et al. Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1702-11. doi: 10.1161/01.ATV.0000229218.97976.43. Epub 2006 May 25. Arterioscler Thromb Vasc Biol. 2006. PMID: 16728653 Review. - Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.
Takahashi S. Takahashi S. J Atheroscler Thromb. 2017 Jun 1;24(6):552-559. doi: 10.5551/jat.RV17004. Epub 2017 Apr 19. J Atheroscler Thromb. 2017. PMID: 28428482 Free PMC article. Review. - Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.
Han J, Hajjar DP, Febbraio M, Nicholson AC. Han J, et al. J Biol Chem. 1997 Aug 22;272(34):21654-9. doi: 10.1074/jbc.272.34.21654. J Biol Chem. 1997. PMID: 9261189 - JAK-STAT-dependent regulation of scavenger receptors in LPS-activated murine macrophages.
Hashimoto R, Kakigi R, Miyamoto Y, Nakamura K, Itoh S, Daida H, Okada T, Katoh Y. Hashimoto R, et al. Eur J Pharmacol. 2020 Mar 15;871:172940. doi: 10.1016/j.ejphar.2020.172940. Epub 2020 Jan 20. Eur J Pharmacol. 2020. PMID: 31968212
Cited by
- Therapeutic peptides for coronary artery diseases: in silico methods and current perspectives.
Aslan A, Ari Yuka S. Aslan A, et al. Amino Acids. 2024 May 31;56(1):37. doi: 10.1007/s00726-024-03397-3. Amino Acids. 2024. PMID: 38822212 Free PMC article. Review. - Karenia brevis Extract Induces Cellular Entry through Distinct Mechanisms in Phagocytic RAW 264.7 Macrophages versus Non-Phagocytic Vero Cells.
Minns LA, Sausman KT, Brown AP, York RA, McCall JR. Minns LA, et al. Mar Drugs. 2023 Dec 19;22(1):4. doi: 10.3390/md22010004. Mar Drugs. 2023. PMID: 38276642 Free PMC article. - Etiology of lipid-laden macrophages in the lung.
Stevenson ER, Smith LC, Wilkinson ML, Lee SJ, Gow AJ. Stevenson ER, et al. Int Immunopharmacol. 2023 Oct;123:110719. doi: 10.1016/j.intimp.2023.110719. Epub 2023 Aug 16. Int Immunopharmacol. 2023. PMID: 37595492 Free PMC article. Review. - Association of monocyte/high-density lipoprotein cholesterol ratio and the carotid intima-media thickness in diabetic patients.
Amouzegar A, Mirzaasgari Z, Mehrabi A, Malek M, Alaei-Shahmiri F, Najafi L, Khajavi A. Amouzegar A, et al. BMC Endocr Disord. 2022 Dec 19;22(1):323. doi: 10.1186/s12902-022-01246-6. BMC Endocr Disord. 2022. PMID: 36536369 Free PMC article. - Antibodies in action: the role of humoral immunity in the fight against atherosclerosis.
Taylor JA, Hutchinson MA, Gearhart PJ, Maul RW. Taylor JA, et al. Immun Ageing. 2022 Dec 2;19(1):59. doi: 10.1186/s12979-022-00316-6. Immun Ageing. 2022. PMID: 36461105 Free PMC article. Review.
References
- Steinberg D. 2002. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 8 1211–1217. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources